Animal models for the negative symptoms of schizophrenia

被引:157
作者
Ellenbroek, BA [1 ]
Cools, AR [1 ]
机构
[1] Univ Nijmegen, Dept Psychoneuropharmacol, NL-6500 HB Nijmegen, Netherlands
来源
BEHAVIOURAL PHARMACOLOGY | 2000年 / 11卷 / 3-4期
关键词
schizophrenia; negative symptoms; positive symptoms; animal models;
D O I
10.1097/00008877-200006000-00006
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Negative or defect symptoms refer to a reduction in normal functioning. In schizophrenia, negative symptoms encompass, among others, anhedonia, flat affect, avolition and social withdrawal. These symptoms have been found to be particularly prominent in the more chronic phase of the illness and seem to be virtually insensitive to current antipsychotic treatment. This review focuses on the possibilities and limitations of animal models for the negative symptoms of schizophrenia. Following a review of the negative symptoms in schizophrenia, attention is focused on the two symptoms most often modelled in animals - anhedonia and social withdrawal. We then look at the important question of how to model schizophrenic pathology in animals. Since the exact pathology is still far from clear, most efforts have in the past concentrated on using psychotomimetic drugs such as amphetamine or phencyclidine. The recently accumulated knowledge that schizophrenia probably results from disturbances in the normal development of the brain has led to a surge of new animal models in which the long-term consequences of early manipulations are investigated. However, so far these models have predominantly concentrated on the positive rather than the negative symptoms of schizophrenia. The last part of this review is dedicated to the question of validation of animal models for anhedonia and social withdrawal. The general conclusion is that very few models have so far been adequately tested. The lack of currently effective treatment further hampers the study of such validation. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:223 / 233
页数:11
相关论文
共 108 条
[91]   YAWNING AND SUPPRESSION OF EXPLORATION INDUCED BY DOPAMINE AGONISTS - NO RELATION TO EXTRACELLULAR STRIATAL LEVELS OF DOPAMINE [J].
STAHLE, L ;
UNGERSTEDT, U .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (01) :201-209
[92]   THE EFFECTS OF HALOPERIDOL AND CLOZAPINE ON PCP-INDUCED AND AMPHETAMINE-INDUCED SUPPRESSION OF SOCIAL-BEHAVIOR IN THE RAT [J].
STEINPREIS, RE ;
SOKOLOWSKI, JD ;
PAPANIKOLAOU, A ;
SALAMONE, JD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 47 (03) :579-585
[93]   PREMORBID ADJUSTMENT IN SCHIZOPHRENIA - CONCEPTS, MEASURES, AND IMPLICATIONS .1. CONCEPT OF PREMORBID ADJUSTMENT [J].
STRAUSS, JS ;
KOKES, RF ;
KLORMAN, R ;
SACKSTEDER, JL .
SCHIZOPHRENIA BULLETIN, 1977, 3 (02) :182-185
[94]   Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine treated rats [J].
Swerdlow, NR ;
Bakshi, V ;
Waikar, M ;
Taaid, N ;
Geyer, MA .
PSYCHOPHARMACOLOGY, 1998, 140 (01) :75-80
[95]  
TALAMINI L, 2000, IN PRESS ANN NY ACAD
[96]   Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia [J].
Talamini, LM ;
Koch, T ;
Ter Horst, GJ ;
Korf, J .
BRAIN RESEARCH, 1998, 789 (02) :293-306
[97]  
Tollefson GD, 1997, AM J PSYCHIAT, V154, P466
[98]   The delayed effects of phencyclidine (PCP) disrupt latent inhibition in a conditioned taste aversion paradigm [J].
Turgeon, SM ;
Auerbach, EA ;
Heller, MA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (02) :553-558
[99]   Isolation changes the incentive value of sucrose and social behaviour in juvenile and adult rats [J].
Van den Berg, CL ;
Pijlman, FTA ;
Koning, HAM ;
Diergaarde, L ;
Van Ree, JM ;
Spruijt, BM .
BEHAVIOURAL BRAIN RESEARCH, 1999, 106 (1-2) :133-142
[100]   DEXTRO-AMPHETAMINE DIMINISHES NEGATIVE SYMPTOMS IN SCHIZOPHRENIA [J].
VANKAMMEN, DP ;
BORONOW, JJ .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1988, 3 (02) :111-121